Genmab — August 2015
-
Det er også en mulighed.

-
Interview med Jan på børsen
http://play.borsen.dk/social/55dff58dac79c95260fa2852 -
Paul P er med på mange patenter: https://www.google.com/search?tbm=pts&hl=da&q=Paul+Parren&gws_rd=ssl#hl=da&tbm=pts&q=Paul+Parren+bispecific
-
Hvis han virkelig har sagt "1000 fold" i forbindelse med EM1 så er det nyt i forhold til dette abstract der siger "55-65 fold" : http://mct.aacrjournals.org/content/12/11_Supplement/B241.short
-
Apropos patenter: http://www.freshpatents.com/-dt20150820ptan20150231235.php
-
Apropos Jan så mht hans kommentar på Dara salg. Han siger analytikerne ligger på 5+1 milliarder $ (Nordea endda kun på 4 indtil videre
) og at både Genmab internt og Jansen kun kan bekræfte dette. Oveni købet nok højere siger han - uden dog at ville nævne tal.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
